Maxigen Biotech Inc. (TPE:1783)
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST
| Market Cap | 2.85B -25.5% |
| Revenue (ttm) | 856.96M +8.1% |
| Net Income | 303.01M +29.5% |
| EPS | 3.35 +29.3% |
| Shares Out | 89.70M |
| PE Ratio | 9.49 |
| Forward PE | n/a |
| Dividend | 2.00 (6.29%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 172,217 |
| Open | 33.80 |
| Previous Close | 33.80 |
| Day's Range | 31.70 - 34.10 |
| 52-Week Range | 31.70 - 48.30 |
| Beta | 0.42 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 12, 2027 |